ArticleCardiovascular research2018

Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.

Nobutoshi Matsumura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.